All Years
Cantor senior fintech and digital analyst Ramsey El-Assal has watched as blockchain technology grew from its infancy. Now, he believes its mainstream moment has arrived. Disclaimer – Cantor | Cantor
27 January, 2026The institutional adoption of cryptocurrency has accelerated over the past year. Senior crypto analyst Brett Knoblauch shares his perspective on this shift and Cantor’s commitment to supporting the sector. Disclaimer – Cantor | Cantor
23 January, 2026The closing of Twenty One Capital (NYSE: $XXI)’s combination with $CEP marks a watershed moment for Bitcoin DATs. As Chairman Brandon Lutnick explains, Cantor Fitzgerald’s SPAC and Crypto leadership played a key role in bringing the deal to life.
11 December, 2025Investors have been eagerly awaiting a stronger IPO market for years, and Beau Bohm, Cantor’s Global Co-Head of Equity Capital Markets, is noticing signs of a shift finally materializing. Hear about what he’s observing, particularly in the tech, fintech, and industrials sectors. Disclaimer – Cantor | Cantor
29 October, 2025Radiopharmaceuticals are rapidly transforming oncology by offering unprecedented potency in targeting tumor cells. Senior Biotech Analyst Li Watsek explains the science and logistics behind this highly effective radiation therapy. Disclaimer – Cantor | Cantor
22 October, 2025Cantor’s Beau Bohm lays out some of the trends that signify to him the IPO market is finding its rhythm again. Disclaimer – Cantor | Cantor
26 August, 2025Commercial space exploration is poised to advance in light of the latest presidential executive order aimed at increasing launch missions and industry competition. Senior Research Analyst Andres Sheppard examines how policy developments and technological advances are helping exploration reach new heights. Disclaimer – Cantor | Cantor
20 August, 2025Staying ahead of the curve is crucial for identifying biotech companies with growth potential. Senior Biotech Analyst Steve Seedhouse monitors novel approaches, such as RNA editing, to evaluate their advancements in treatment and positive impacts on health outcomes. Disclaimer – Cantor | Cantor
4 August, 2025Cantor serves as a trusted strategic advisor for many early-to-mid-stage growth companies. Mark Baillie, MD, Enterprise Software Investment Banking, shares some strategies and opportunities that emerging business owners may not know how to effectively leverage on their own. Disclaimer – Cantor | Cantor
4 June, 2025Self-driving technology is putting the pedal to the metal—turns out, the future might not need a driver’s license. Senior Equity Research Analyst Andres Sheppard explains how advancements in self-driving vehicles—both for consumers and commercial—are meeting market needs and how evolving regulations could help move the technology forward. Disclaimer – Cantor | Cantor
19 May, 2025Technological advances are key to solving for both increasing energy demand and the need for efficiency, says Cole Bader, Cantor’s Global Head of Technology Investment Banking. Disclaimer – Cantor | Cantor
15 May, 2025Mark Baillie, a managing director in Cantor’s Technology Investment Banking Group, works with enterprise software clients to grow through investment or M&A. In this edition of Cantor Calls, Mark explains how he advises clients to differentiate themselves in the modern technology vendor landscape, while drawing on familiar technology challenges existing for decades. Disclaimer – Cantor | […]
13 May, 2025